Hysteroscopic endometrial laser ablation – A novel approach for palliative management of endometrial cancer in inoperable patients
Our findings highlight the potential of conscious HEA as a palliative management strategy in high-risk patient populations, emphasizing its role when conventional therapies fail. This study underscores the importance of personalized treatment plans and multidisciplinary approaches in managing endometrial cancer, paving the way for further research into the safety and efficacy of HEA in similar cohorts.
Authors
- Dan Grisaru (ORCID: https://orcid.org/0000-0001-8860-9619)
- Neta Solomon (ORCID: https://orcid.org/0000-0002-4181-1657)
- Michael Lavie (ORCID: https://orcid.org/0000-0002-8431-8563)
- Nadav Michaan (ORCID: https://orcid.org/0000-0001-7987-404X)
- Gilad Rattan
- Ido Laskov (ORCID: https://orcid.org/0000-0002-5061-0670)
- Shai Ram (ORCID: https://orcid.org/0000-0002-2860-9438)
- Dana Englander
Institutions
- Tel Aviv University (IL)
- Tel Aviv Sourasky Medical Center (IL)
Publication Details
- Journal
- Gynecologic Oncology Reports
- Published
- 2025-03-27
- DOI
- https://doi.org/10.1016/j.gore.2025.101728
- Primary Topic
- Uterine Myomas and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00